Asthika Goonewardene
Stock Analyst at Truist Securities
(1.27)
# 3,438
Out of 4,868 analysts
97
Total ratings
36.47%
Success rate
-14.29%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Asthika Goonewardene
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IGMS IGM Biosciences | Maintains: Hold | $2 → $1 | $1.19 | -15.97% | 9 | Jun 11, 2025 | |
| BNTX BioNTech SE | Reiterates: Buy | $151 → $155 | $104.97 | +47.66% | 2 | Jun 3, 2025 | |
| MRSN Mersana Therapeutics | Maintains: Buy | $9 → $10 | $0.35 | +2,729.65% | 4 | May 16, 2025 | |
| LEGN Legend Biotech | Maintains: Buy | $88 → $71 | $34.70 | +104.61% | 2 | May 14, 2025 | |
| ALLO Allogene Therapeutics | Maintains: Buy | $14 → $10 | $1.30 | +669.23% | 7 | May 14, 2025 | |
| AUTL Autolus Therapeutics | Maintains: Buy | $11 → $10 | $2.03 | +392.61% | 4 | Apr 1, 2025 | |
| GMAB Genmab | Maintains: Buy | $50 → $45 | $22.03 | +104.27% | 14 | Mar 11, 2025 | |
| IOVA Iovance Biotherapeutics | Maintains: Buy | $25 → $15 | $2.02 | +642.57% | 6 | Mar 3, 2025 | |
| CRGX CARGO Therapeutics | Downgrades: Hold | $32 → $7 | $4.38 | +59.82% | 3 | Jan 30, 2025 | |
| EXEL Exelixis | Maintains: Buy | $42 → $43 | $41.36 | +3.98% | 8 | Jan 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $19.85 | +76.32% | 1 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $87 → $136 | $62.88 | +116.28% | 5 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $83 → $97 | $108.00 | -10.19% | 1 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $15 | $0.79 | +1,798.49% | 6 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $44 | $8.70 | +405.75% | 1 | Jun 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $69 → $88 | $53.08 | +65.79% | 2 | Jun 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $4 | $1.65 | +142.42% | 5 | May 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 | $1.16 | +1,537.93% | 3 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $1.31 | +2,953.44% | 4 | Sep 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $27 | $0.67 | +3,916.06% | 2 | Sep 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Hold | $120 | $27.85 | +330.88% | 1 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $100 → $60 | $1.77 | +3,289.83% | 3 | Aug 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $15 | $0.45 | +3,222.26% | 4 | Aug 23, 2022 |
IGM Biosciences
Jun 11, 2025
Maintains: Hold
Price Target: $2 → $1
Current: $1.19
Upside: -15.97%
BioNTech SE
Jun 3, 2025
Reiterates: Buy
Price Target: $151 → $155
Current: $104.97
Upside: +47.66%
Mersana Therapeutics
May 16, 2025
Maintains: Buy
Price Target: $9 → $10
Current: $0.35
Upside: +2,729.65%
Legend Biotech
May 14, 2025
Maintains: Buy
Price Target: $88 → $71
Current: $34.70
Upside: +104.61%
Allogene Therapeutics
May 14, 2025
Maintains: Buy
Price Target: $14 → $10
Current: $1.30
Upside: +669.23%
Autolus Therapeutics
Apr 1, 2025
Maintains: Buy
Price Target: $11 → $10
Current: $2.03
Upside: +392.61%
Genmab
Mar 11, 2025
Maintains: Buy
Price Target: $50 → $45
Current: $22.03
Upside: +104.27%
Iovance Biotherapeutics
Mar 3, 2025
Maintains: Buy
Price Target: $25 → $15
Current: $2.02
Upside: +642.57%
CARGO Therapeutics
Jan 30, 2025
Downgrades: Hold
Price Target: $32 → $7
Current: $4.38
Upside: +59.82%
Exelixis
Jan 27, 2025
Maintains: Buy
Price Target: $42 → $43
Current: $41.36
Upside: +3.98%
Jan 8, 2025
Initiates: Buy
Price Target: $35
Current: $19.85
Upside: +76.32%
Nov 12, 2024
Maintains: Buy
Price Target: $87 → $136
Current: $62.88
Upside: +116.28%
Nov 8, 2024
Maintains: Hold
Price Target: $83 → $97
Current: $108.00
Upside: -10.19%
Aug 16, 2024
Maintains: Buy
Price Target: $18 → $15
Current: $0.79
Upside: +1,798.49%
Jun 24, 2024
Maintains: Buy
Price Target: $50 → $44
Current: $8.70
Upside: +405.75%
Jun 4, 2024
Maintains: Buy
Price Target: $69 → $88
Current: $53.08
Upside: +65.79%
May 21, 2024
Maintains: Buy
Price Target: $5 → $4
Current: $1.65
Upside: +142.42%
May 16, 2024
Maintains: Buy
Price Target: $19
Current: $1.16
Upside: +1,537.93%
Sep 6, 2023
Reiterates: Buy
Price Target: $40
Current: $1.31
Upside: +2,953.44%
Sep 6, 2023
Reiterates: Buy
Price Target: $27
Current: $0.67
Upside: +3,916.06%
Apr 5, 2023
Reinstates: Hold
Price Target: $120
Current: $27.85
Upside: +330.88%
Aug 23, 2022
Maintains: Hold
Price Target: $100 → $60
Current: $1.77
Upside: +3,289.83%
Aug 23, 2022
Maintains: Buy
Price Target: $19 → $15
Current: $0.45
Upside: +3,222.26%